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ABSTRACT
The genome-wide distribution patterns of the ‘6th
base’ 5-hydroxymethylcytosine (5hmC) in many
tissues and cells have recently been revealed
by hydroxymethylated DNA immunoprecipitation
(hMeDIP) followed by high throughput sequencing or
tiling arrays. However, it has been challenging to
directly compare different data sets and samples
using data generated by this method. Here, we
report a new comparative hMeDIP-seq method,
which involves barcoding different input DNA
samples at the start and then performing hMeDIP-
seq for multiple samples in one hMeDIP reaction.
This approach extends the barcode technology from
simply multiplexing the DNA deep sequencing
outcome and provides significant advantages for
quantitative control of all experimental steps, from
unbiased hMeDIP to deep sequencing data analysis.
Using this improved method, we profiled and
compared the DNA hydroxymethylomes of mouse
ES cells (ESCs) and mouse ESC-derived neural pro-
genitor cells (NPCs). We identified differentially
hydroxymethylated regions (DHMRs) between ESCs
and NPCs and uncovered an intricate relationship
between the alteration of DNA hydroxymethylation
and changes in gene expression during neural
lineage commitment of ESCs. Presumably, the
DHMRs between ESCs and NPCs uncovered by this
approach may provide new insight into the function of
5hmC in gene regulation and neural differentiation.
Thus, this newly developed comparative hMeDIP-seq
method provides a cost-effective and user-friendly
strategy for direct genome-wide comparison of DNA
hydroxymethylation across multiple samples, lending
significant biological, physiological and clinical
implications.
INTRODUCTION
DNA methylation at the 5-position of cytosine (5mC) is
an important epigenetic modiﬁcation that plays crucial
roles in mammalian development and cell differentiation
(1). Recent studies show that this apparently stable modi-
ﬁcation can be removed via oxidation by the ten-eleven
translocation (TET) family of proteins. TET proteins
oxidize 5mC to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)
(2–4). Among the three 5mC oxidative derivatives,
5hmC is the most abundant form in vivo and can be
detected in almost all mammalian tissues and cells (4–8).
In addition to being one of the intermediate states of
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epigenetic modiﬁcation (9–11).
Genome-wide mapping of 5mC and 5hmC reveals the
genomic locations of these modiﬁcations, which is im-
portant for the elucidation of their functions (10,11).
Several groups have used 5hmC-speciﬁc afﬁnity
pull-down techniques [for example, hydroxymethylated
DNA immunoprecipitation (hMeDIP)] followed by
next-generation sequencing (NGS) or tiling arrays to
proﬁle the genome-wide 5hmC distribution in brain
tissues and embryonic stem cells (12–18). However, due
to a few limitations buried in the conventional
hMeDIP-seq method, it remains challenging to use
DNA hydroxymethylome data generated by conventional
hMeDIP-seq to perform direct genome-wide comparative
analysis between high- and low-5hmC samples. For
example, the current standard protocol of Illumina
NGS requires loading of the same amount of DNA
libraries for different samples in cluster generation and
sequencing, which cancels out the differences in hMeDIP
products among different samples (especially for those
with differential 5hmC abundance). In addition, the
multiple steps of the conventional hMeDIP-seq method,
including hMeDIP, library construction, cluster hybrid-
ization and sequencing, may amplify experimental vari-
ation across the samples. Many laboratories have
developed elegant computational methods to normalize
or adjust the DNA methylome data generated from dif-
ferent samples (19–22). However, the bias caused by the
intrinsic limitations of the conventional MeDIP-seq or
hMeDIP-seq methods has not yet been overcome. The
dramatic variation of 5hmC levels among distinct tissues
and cells or during cell differentiation and embryo devel-
opment demands new strategies or approaches to
overcome these technical difﬁculties (6,23).
We reasoned that if the multiple steps required for
hMeDIP-seq can be performed in one reaction system
with multiple samples being compared, the experimentally
induced variation could be signiﬁcantly reduced, therefore
overcoming the aforementioned limitation of the conven-
tional hMeDIP-seq. To address this issue, we applied
barcode technology (multiple index sequencing), which
has recently been developed to distinguish different
DNA samples in next-generation sequencing (24,25).
The sequence reads of hMeDIP, as well as input, can be
sorted into several groups representing different samples
based on their speciﬁc barcode, which is assigned to each
sample before performing the hMeDIP. Importantly, this
modiﬁed hMeDIP strategy makes the obtained hMeDIP-
seq data from multiple samples with different levels of
5hmC accessible for accurate comparative analysis. This
approach has been successfully used to compare the
hydroxymethylomes of the benign nevus and melanoma
(26). In this report, we ﬁrst describe the methodology of
this approach in detail and then demonstrate its broad
application in understanding the functional role of
5hmC during neural differentiation. In particular, we
identiﬁed the genome-wide differentially hydroxymeth-
ylated regions (DHMRs) between mouse embryonic
stem cells (ESCs) and neural progenitor cells (NPCs),
and analysed their correlation with changes in gene
expression. Together, our studies reveal dynamic
changes in DNA hydroxymethylation during neural dif-
ferentiation of ESCs and suggest that this barcode-based
comparative hMeDIP-seq method can be used to compare
the 5hmC patterns of multiple biological or pathological
samples.
MATERIALS AND METHODS
Cell culture
46C mouse ES cells (generously given by Dr Qi-Long
Ying, USC) were cultured in high-glucose Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Hyclone-
ThermoScientiﬁc) supplemented with 10% fetal bovine
serum (Invitrogen), 0.1mM non-essential amino acid
(Invitrogen), 0.1mM b-mercaptoethanol (Invitrogen)
and 1000 U/ml leukaemia inhibitory factor (Millipore).
ESC-derived NPCs were differentiated from 46C ES
cells according to the monolayer neural differentiation
protocol (27,28). Rosette-like Sox1-GFP+ NPCs (>95%
Sox1-GFP+NPCs) were used in our experiments at day 9
upon neural differentiation.
Immunoﬂuorescence
Cells were ﬁxed in 4% paraformaldehyde and penetrated
using PBS with 0.1% Triton X-100. Cellular DNA was
denatured for 30min by 2N HCl followed by neutraliza-
tion for 5min using 100mM Tris, pH 8.0. After blocking
in 5% serum for 1h, cells were incubated with anti-5hmC
antibody (1:5000) (active motif). After washing, cells were
incubated with Cy3-labelled anti-rabbit IgG (beyond
time), and the nuclei were labelled by DAPI.
Fluorescence was observed and recorded using Leica
Microscopy.
Reverse transcription-quantitative PCR (RT-qPCR)
RNA was extracted using Trizol reagent (Invitrogen) ac-
cording to the manufacturer’s protocol. One microgram
RNA was used for reverse transcription by kit
(TAKARA). The 20ml cDNA was diluted into 200ml.
The transcript levels of Tet1, Tet2 and Tet3 were
measured using quantitative real-time PCR with condi-
tions: 95 C for 2min followed by 40 cycles at 95 C for
15s and 60 C for 31s. Quantitative real-time PCR was
carried in an iQ5 real-time PCR cycler (Bio-Rad) using
the premixed 2  real-time SYBR Green reagent
(TAKARA). Sequences of primers are described in
Supplementary Table S1.
Dot blot analysis
Genomic DNA was extracted from cells using DNeasy
Blood and Tissue kit (Qiagen). Denatured DNA was
spotted on a nitrocellulose membrane (Waterman) and
cross-linked by UVC (ultraviolet C) irradiation (Hoefer)
for 5min. The membrane was then blocked with 5% milk
in TBS-Tween 20 for 1h and incubated with anti-5hmC
antibody (1:10000) (active motif) at 4 C overnight. After
incubation with a horse radish peroxidase (HRP)-
conjugated anti-rabbit IgG (beyond time) for 1h at
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TBS-Tween 20 three times and then DNA was detected
by Western blotting analysis system (Kodak) using
enhanced chemiluminescence (GE-Healthcare). The dot
blot intensity was quantiﬁed by Image-J software (NIH).
Comparative hMeDIP-seq
Library construction (adding adaptor containing
barcode sequence)
Genomic DNA was sonicated to <500bp by Bioruptor
sonicator (Diagenode) and quantiﬁed using the
Quant-iTdsDNA HS assay kit (Invitrogen) according to
the manufacturer’s manual. The sonicated DNA frag-
ments (4mg of each sample) were end-repaired using the
End-It DNA End Repair Kit (EPICENTRE Biotech-
nologies) according to the manufacturer’s instructions,
followed by treatment with Klenow fragment 30–50exo
(NEB) and dATP to generate a protruding 30A for
ligation with the adaptor containing a speciﬁc barcode
sequence. The barcode sequence (four-base index:
CCAG and TAGC) within the adaptor was designed as
described previously (24) with some modiﬁcations.
hMeDIP
Equal amounts ( 4mg) of barcode-tagged gDNA from
ESCs and NPCs were pooled together in one tube. The
mixed DNA was denatured and diluted by IP buffer (10%
was taken off as input at this step). The denatured DNA
was incubated with 4ml anti-5hmC antibody (active motif)
at 4 C overnight. Antibody–DNA complexes were
captured by protein A/G beads, and the enriched
5hmC-containing DNA fragments (hMeDIP product)
were puriﬁed.
Library ampliﬁcation
The hMeDIP products, as well as input DNA, were
ampliﬁed for 10–12 cycles, and the PCR products were
puriﬁed by Qiagen Mini Gel Puriﬁcation Kit.
Next-generation sequencing
The ampliﬁed libraries were submitted for cluster growth
and sequencing by the Illumina Genome Analyzer II
(GAII).
hMeDIP-seq data processing
The image analysis and base calling were performed with
the Illumina package OLB (v1.8). We separated the raw
sequence reads of hMeDIP and Input into different ﬁles,
according to the speciﬁc barcode sequences (4-bp) at 50-
end of each sequence read.
Sequence reads were mapped onto the reference mouse
genome (NCBI Build UCSC mm9) using the Bowtie
(v0.12.7) algorithm (29). Unique and monoclonal reads
were used for further analysis. Since the average DNA
fragment length used in hMeDIP-seq was 350bp, each
sequence was extended to 350 bp. Summary of
hMeDIP-seq data is shown in Supplementary Table S2.
The sequencing data have been deposited in the Gene
Expression Omnibus database under accession number
GSE40810.
The distribution of 5hmC reads at promoters or in gene
body regions was analysed by house-made software (13).
The 5hmC-enriched regions (5hmC peaks) were identiﬁed
using MACS (v1.4) at P<1e-5 and FDR<0.01 (30). The
5hmC peaks were annotated to mouse Refseq genes and
the genes with 5hmC peaks at promoters or in gene body
regions were chosen for further analysis.
Analysis of the relationship between DNA
hydroxymethylation and gene expression
Gene expression data of ESCs (31) and NPCs (32) were
downloaded from GEO dataset [Accession number of
GEO: ESCs (ES_rep1: GSM198062, ES_rep2:
GSM198063, ES_rep3: GSM198064), NPCs (NPC_rep1:
GSM618399, NPC_rep2: GSM618400)]. The raw CEL
ﬁles were processed by robust multi-array average
(RMA), and log2 intensities were used to represent the
expression levels after normalization between samples.
Genes were separated into ﬁve groups with respect to
their average signals of probes, and the 5hmC distribution
at promoters and in gene body regions of these ﬁve groups
of genes were plotted for ESCs and NPCs, respectively.
The genes were also classiﬁed into ‘5hmC+’ and
‘5hmC ’ groups according to the presence or absence of
5hmC peaks at either promoters [TSS (transcription start
site ) ±1kb] or gene body regions [from ‘TSS+1kb’ to
‘TES (transcription end site)’]. The differences in average
gene expression levels between these groups of genes were
analysed by ANOVA.
Identiﬁcation of DHMRs
Pooled 5hmC peaks were called from the un-separated
hMeDIP-seq data by MACS (30), and the densities of
5hmC peaks were compared between ESCs and NPCs.
For the quantitative analysis, the densities of 5hmC
peaks between ESCs and NPCs were normalized by
their input respectively. The threshold was set at 1-fold
(NPCs versus ESCs, log2 5hmC density ratio 1
or  1) for identiﬁcation of ‘DNA de-hydro-
xymethylation (loss of 5hmC)’ regions and ‘de novo
DNA hydroxymethylation (gain of 5hmC)’ regions
during neural differentiation.
hMeDIP-qPCR
Two microgram sonicated gDNA was denatured and
incubated with 1ml anti-5hmC antiserum (active motif)
for hMeDIP as described previously (13,33). Normal
IgG antibodies were used as control. Input and hMeDIP
products were used as templates for quantitative real-time
PCR. Relative 5hmC enrichment was calculated by 2
dCt
(dCt=CtInput   CthMeDIP). Primers used in hMeDIP-
qPCR are described in Supplementary Table S3.
Glucosylation of genomic DNA followed by
methylation-sensitive qPCR (glucMS-qPCR)
The ‘5hmC’ and ‘5hmC+5mC’ levels in DHMRs contain-
ing MspI/HpaII sites were measured by a restriction
enzyme-based assay (EpiMark kit, NEB) (34). Genomic
DNA was treated with or without T4 Phage
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no enzyme (mock digestion). The MspI- and
HpaII-resistant fraction was quantiﬁed by qPCR using
primers designed around at least one HpaII/MspI site,
and normalizing to the mock digestion. Primers used in
glucMS-qPCR are described in Supplementary Table S4.
Gene ontology (GO) analysis
GO analysis for genes with ‘gain of 5hmC’ DHMRs was
performed by the database for annotation, visualization
and integrated discovery (DAVID) website (35,36). GO
analysis for the ‘gain of 5hmC’ DHMRs was also per-
formed by the Genomic Regions Enrichment of
Annotations Tool (GREAT) (37).
Analysis of the relationship between the changes in
DNA hydroxymethylation and gene expression during
neural differentiation
The genes were sorted according to the changes in gene
expression level: genes that were down-regulated and
genes that were up-regulated during neural differentiation
(log2 mRNA value   1o r 1). The changes in tag
density of 5hmC peaks at promoters (TSS±1kb) or in
gene body regions (from TSS+1kb to TES) were
compared between the up- and down- regulated genes by
ANOVA.
All 5hmC peaks located at promoters (TSS±1kb) or
gene body regions (from TSS+1kb to TES) were selected
for dot plotting. The alteration in 5hmC density for each
5hmC peak was plotted on the y-axis and the change in
corresponding gene expression was plotted on the x-axis.
Correlation between the changes in 5hmC and gene ex-
pression was analysed by linear regression analysis.
RESULTS
Strategy for comparative hMeDIP-seq method
To compare the DNA hydroxymethylomes of diverse cell
types, we optimized the conventional hMeDIP-seq
method in multiple aspects (as illustrated in Figure 1).
For instance, after sonication, the genomic DNA frag-
ments from different samples were labelled with
adaptors containing speciﬁc barcode sequences. Equal
amounts of barcode-tagged DNA fragments from differ-
ent samples were then pooled together in one tube for
hMeDIP (the input was taken out before IP). The
hMeDIP and input libraries were ampliﬁed and sequenced
using Illumina GAII. The raw reads from different
samples were sorted according to their speciﬁc barcode
sequences, and mapped to the genome for further bio-
informatic analysis. Immunoprecipitation and sequencing
of multiple samples in one reaction system markedly
reduce the experimental variation among samples and
enable direct comparison of the DNA hydroxy-
methylation data across samples. Thus, we refer to
this new approach as the ‘comparative hMeDIP-seq
method’.
Reduced global 5hmC level in NPCs as compared
with ESCs
Epigenetic modiﬁcations undergo dynamic changes during
cell differentiation and development. Directed differenti-
ation of pluripotent mouse ESCs into NPCs in vitro is a
well-established model for the study of molecular mech-
anisms controlling neural induction. Therefore, we used
the newly developed comparative hMeDIP-seq method
to examine the genome-wide differences in DNA
hydroxymethylation in ESCs and ESC-derived NPCs. A
sufﬁcient number of NPCs were obtained with high purity
from mouse ESCs via N2B27 serum-free monolayer dif-
ferentiation in vitro (Supplementary Figure S1a–c). We
compared the expression levels of Tet family genes as
well as the global 5hmC levels in ESCs versus NPCs.
RT-qPCR analysis revealed that Tet1 mRNA level,
which was high in ESCs, decreased dramatically in
NPCs, while Tet3 was up-regulated in NPCs but only
marginally expressed in ESCs (Figure 2a). However,
Tet2 mRNA levels were comparable between ESCs and
NPCs (Figure 2a). Both immunoﬂuorescence (Figure 2b)
and dot blot analysis (Figure 2c) showed that the global
5hmC levels in NPCs were much lower than those in
ESCs, suggesting that pluripotent ESCs and neural
lineage-committed NPCs are in two different developmen-
tal stages with high and low 5hmC abundance, respect-
ively. As expected, comparative hMeDIP-seq data showed
that the 5hmC reads of ESCs and NPCs (after normalized
to the corresponding input) were in complete agreement
with changes of the global 5hmC levels detected between
ESCs and NPCs by dot blot (Figure 2d). These data
indicate that the new comparative hMeDIP-seq method
preserves the relative difference in 5hmC abundance
across different samples.
The average distribution of 5hmC was mapped onto an
average gene model. ESCs exhibited a hypo-hydroxy-
methylated ‘valley’ with a small ‘bumper’ around TSS
regions, but signiﬁcant 5hmC enrichment was found
across gene body regions (Figure 2e), consistent with the
previously reported 5hmC pattern in ESCs (13–15).
However, neither a 5hmC dip with a small ‘bumper’
around TSS regions nor signiﬁcant 5hmC enrichment in
gene body regions was observed in NPCs (Figure 2f). This
suggests that both the total level of 5hmC and the genomic
distribution of 5hmC are dramatically different between
ESCs and NPCs (38).
Recent reports have suggested signiﬁcant 5hmC enrich-
ment at enhancers (deﬁned by the enrichment of both
H3K4me1 and H3K27ac histone modiﬁcations) in ESCs
(17,39–42). Therefore, we next examined the association
of 5hmC with the annotated enhancers and DNase I hyper-
sensitive sites (DHSs), as well as the loss of 5hmC at these
newlydeﬁnedgenomicelements duringESCtoNPCdiffer-
entiation. Consistent with previous ﬁndings, we observed
signiﬁcant 5hmC enrichment at the enhancers in ESCs
(Supplementary Figure S2a). Interestingly, this 5hmC
enrichment at ESC enhancers is lost in NPCs
(SupplementaryFigureS2a).Wealsoanalysedtherelation-
ship of 5hmC and DHSs. We separated DHSs into three
classes: (i) those lacking the enhancerhistone modiﬁcations
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bearing only H3K4me1; and (iii) putative active enhancers
with both modiﬁcations. DHSs with poised or active
enhancer chromatin signatures exhibit 5hmC enrichment,
and poised enhancers have even higher 5hmC levels than
active enhancers (Supplementary Figure S2b–d). These ob-
servations indicate that DNA hydroxymethylation may be
involved in regulating the function of enhancers.
It is noteworthy that the comparative hMeDIP-seq
approach (two samples in one lane) generated fewer
5hmC reads and peaks for individual samples (for
example ESCs) than the conventional hMeDIP-seq
approach (one sample in one lane). However, the 5hmC
distribution patterns were consistent between the com-
parative and conventional hMeDIP-seq methods
(Supplementary Figure S3a–d), suggesting that the new
comparative hMeDIP-seq method yields similar results,
albeit at the expense of throughput. If higher throughput
data is required, it would be necessary to sequence the
library in more lanes and combine the data together for
analysis.
Correlation between DNA hydroxymethylation and
gene expression status
To determine whether there is a relationship between
DNA hydroxymethylation and gene expression status in
the same cell type, we classiﬁed genes into ﬁve groups
based on their transcriptional levels and plotted their
5hmC distribution patterns at promoters and gene body
regions. As shown in Figure 3a, genes with high expression
levels in ESCs exhibited 5hmC depletion around TSS
regions, whereas genes with low expression levels dis-
played 5hmC enrichment at promoters. A similar
negative correlation between 5hmC density around TSS
regions and gene expression was also observed in NPCs
(Figure 3b). Consistent with the previous ﬁndings, all ﬁve
groups of genes have abundant 5hmC enrichment in gene
body regions in ESCs, and genes with high expression
levels displayed higher 5hmC enrichment than genes at
low expression levels (Figure 3a). However, in NPCs, the
5hmC curves of all ﬁve groups of genes could not be easily
separated from each other because 5hmC was not particu-
larly enriched in gene body regions (Figure 3b).
We also separated genes into ‘5hmC+’ and ‘5hmC ’
groups according to the presence or absence of 5hmC
peak (s) at promoters (TSS±1kb) or gene body regions
(from TSS+1kb to TES) and compared their average
gene expression levels. In ESCs, genes with 5hmC peaks
at promoters (TSS±1kb) had lower average expression
levels than those without 5hmC peaks, while genes with
5hmC peaks in the gene body regions (from TSS+1kb to
TES) had higher expression levels than those without
5hmC peaks (Figure 3c). In NPCs, genes with 5hmC
peaks at promoters (TSS±1kb) also had lower expres-
sion levels than those without 5hmC peaks (Figure 3d).
However, unlike the relationship observed in ESCs, genes
with 5hmC peaks in gene body regions (from TSS+1kb
to TES) in NPCs had lower expression levels than the
genes without 5hmC peaks (Figure 3d). Thus, these data
suggest that DNA hydroxymethylation in gene body
regions correlates differently with gene expression depend-
ing on the cell type.
Identiﬁcation of DHMRs between ESCs and NPCs
Since the numbers and widths of 5hmC peaks were not
consistent between two different samples, it was difﬁcult
to compare the peaks of ESCs and NPCs directly using the
conventional hMeDIP-seq method. It is now possible to
identify peaks from the un-separated (pooled) hMeDIP-
seq data of ESCs and NPCs as the DNA hydrox-
ymethylation-sensitive regions in both cells because the
comparative hMeDIP-seq reactions for two different
samples are performed in one reaction system. The
density of pooled 5hmC peaks in ESCs and NPCs can
then be directly compared after normalization by the
ratio of corresponding input throughput.
Overall, we identiﬁed 127256 pooled 5hmC peaks from
the un-separated hMeDIP-seq data (Figure 4a). Among
them, 107834 regions lose 5hmC (NPCs versus ESCs,
log2 5hmC density ratio  1) during neural differenti-
ation (Figure 4a). However, we also detected 2748
regions that underwent ‘de novo DNA hydroxy-
methylation (gain-of-5hmC)’ (NPCs versus ESCs, log2
5hmC density ratio 1) (Figure 4a). Importantly, the
DHMRs between ESCs and NPCs can be validated by
hMeDIP-qPCR and glucMS-qPCR analysis using a rep-
resentative set of DHMRs. As shown in Figure 4b–e, the
5hmC peaks at Ankrd23 and Hist1h2aa exhibited ‘loss of
5hmC’ upon neural differentiation, while the 5hmC peaks
at Ftl1 and Irf2bp2 genes underwent ‘de novo hydroxy-
methylation (gain of 5hmC)’.
Figure 1. Schematic diagram of the comparative hMeDIP-seq method.
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peaks and ‘gain of 5hmC’ peaks in different genomic
features were compared with the sequence coverage of
these genomic features in the mouse genome. As previ-
ously reported (13,16), the pooled 5hmC peaks are
associated with exons and promoters with a much higher
frequency than with introns and intergenic regions
(relative to the percentage of these genome elements in
proportion to the genome size) (Figure 4f). Strikingly, al-
though the ‘loss of 5hmC’ is a genome-wide feature of the
neural lineage commitment, it is most dramatic in exons
and promoters and less evident in introns and intergenic
regions (Figure 4f), suggesting that the dynamic change of
5hmC likely has a more profound effect on regulation of
the promoters and exons during ESC differentiation. The
‘gain of 5hmC’ peaks show no apparent preference for the
enrichment of these peaks in promoters, exons, introns or
intergenic regions. Nonetheless, Gene Ontogeny (GO)
analysis of the genes with de novo DNA hydroxy-
methylation showed an enrichment of genes involved in
‘dendrite morphogenesis’ and other neural system func-
tions (Supplementary Figure S4 and Supplementary
Table S5). Thus, the functional potential and mechanistic
insight of the ‘gain of 5hmC’ peaks during neural differ-
entiation may warrant future investigation.
Relationship between the dynamic changes of DNA
hydroxymethylation and gene expression during neural
lineage commitment of ESCs
We next asked whether the alteration in DNA hydrox-
ymethylation at promoters (TSS±1kb) or gene body
regions (from TSS+1kb to TES) is associated with the
Figure 2. Differential Tet1/2/3 gene expression and global 5hmC levels in ESCs and NPCs. (a) RT-qPCR analysis of Tet1, Tet2 and Tet3 mRNA
levels in ESCs and NPCs (mean values±SD, n=3). (b) Immunoﬂuorescence analysis of 5hmC levels in ESCs and NPCs. Bar: 50mm. (c) Dot blot
analysis of the global 5hmC levels in the gDNA of ESCs and ESC-derived NPCs. One hundred ﬁfty nanogram gDNA for each dot. (d) The relative
5hmC signal of dot blot and comparative hMeDIP-seq in ESCs and NPCs. *The ratio of hMeDIP/Input reads numbers in ESCs was set as 100%.
(e) Distribution of 5hmC in TSS±5kb and gene body regions in ESCs. (f) Distribution of 5hmC in TSS±5kb and gene body regions in NPCs.
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ment of ESCs. We stratiﬁed genes into two groups:
down-regulated (log2 gene expression ratio  1) and
up-regulated (log2 gene expression ratio 1) genes
during neural differentiation (NPCs versus ESCs) and
compared their changes in 5hmC density. Although the
5hmC peaks at both groups of genes displayed a
dramatic decrease during neural lineage commitment of
ESCs, the 5hmC peaks at down-regulated genes decreased
more than those at up-regulated genes (Figure 5a and b).
Pooled 5hmC peaks at promoters or gene body regions
were plotted according to their changes in 5hmC density
and gene expression during neural lineage commitment of
ESCs. The majority of 5hmC peaks exhibited a decrease in
5hmC density upon neural lineage commitment of ESCs
while a small fraction of 5hmC peaks showed an increase
(Figure 5c and d). As a whole, there is a weak positive
correlation between the changes in 5hmC peak density and
corresponding gene expression during neural lineage com-
mitment of the ESCs (Figure 5c and d).
DISCUSSION
The barcode technology that distinguishes DNA frag-
ments of different samples allows performance of
hMeDIP of multiple samples in one reaction system and
sequencing the products in one lane. Although barcode
technology has been widely used in high throughput
sequencing of multiple samples and reduces cost in
sequencing (24,25), this is the ﬁrst time (to our knowledge)
it has been applied as the ﬁrst step of hMeDIP-seq. This
new application achieves sequencing of multiple samples
in one lane and preserves the 5hmC differences among the
samples throughout the whole process of hMeDIP-seq
(the latter is the most important innovation in this
method). We could eliminate most of the systematic and
technical errors that arise with conventional hMeDIP-seq
method, since the experiment is processed in identical con-
ditions and is internally controlled. The new method has
several advantages: (i) Performing hMeDIP in one tube
for several samples (especially samples with differential
5hmC abundance) allows the equal IP efﬁciency across
Figure 3. Correlation between DNA hydroxymethylation and gene expression in ESCs and NPCs. (a) Genes were separated into ﬁve groups (from
high to low) according to their expression levels in ESCs: top 20%; 20–40%; 40–60%; 60–80%; bottom 20%. The average 5hmC densities of the ﬁve
groups of genes were plotted across the promoter or gene body regions. Left: TSS±5kb regions. Right: gene body regions. (b) Genes were also
separated into ﬁve groups according to their expression levels in NPCs. The average 5hmC densities of the ﬁve groups of genes were plotted across
the promoter or gene body regions. Left: TSS±5kb regions. Right: gene body regions. (c) Genes were classiﬁed into two groups with respect to the
presence (5hmC+) or absence (5hmC ) of 5hmC peak(s) at their promoters (TSS±1kb) or in gene body regions (from TSS+1kb to TES) in ESCs.
Gene expression levels were compared between ‘5hmC+’ and ‘5hmC ’ groups. Left: promoter, P=0; Right: gene body region, P=1.08358e-13.
*P<0.01. (d) Genes were classiﬁed into two groups with respect to the presence (5hmC+) or absence (5hmC ) of 5hmC peak(s) at their promoters
(TSS±1kb) or in gene body regions (from TSS+1kb to TES) in NPCs. Gene expression levels were compared between ‘5hmC+’ and ‘5hmC ’
groups. Left: promoter, P=0.0001; Right: gene body region, P=0. *P<0.01.
PAGE 7 OF 12 Nucleic AcidsResearch, 2013, Vol.41,No. 7 e84Figure 4. Identiﬁcation of DHMRs between ESCs and NPCs. (a) All 5hmC peaks called from the pooled hMeDIP-seq data were separated into
three groups: down-regulated (log2 5hmC density ratio  1), up-regulated (log2 5hmC density ratio 1) and no signiﬁcant change ( 1<log2 5hmC
density ratio<1) 5hmC peaks. (b–e) UCSC genome (mmp9) browser screen shots, hMeDIP-qPCR and glucMS-qPCR validation (mean values±SD,
n=3) of two representative DHMRs with de-hydroxymethylation (Ankrd23 and Hist1h2aa) and two representative DHMRs with de novo
hydroxymethylation (Ftl1 and Irf2bp2). (f) Percentages of pooled 5hmC peaks, ‘gain of 5hmC’ peaks and ‘loss of 5hmC’ peaks located at different
genomic features.
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samples for all steps after barcode tagging, including
hMeDIP, library ampliﬁcation, cluster formation and
sequencing, can reduce accidental and systematic errors
of the experiments; (iii) Sequencing multiple samples in
one lane can reduce the cost; (iv) For the comparison
across different samples by this method, it is not necessary
to reach saturated sequencing coverage in any samples,
although more hydroxymethylated loci could be identiﬁed
with more sequencing coverage; and (v) Finally and most
importantly (also see below), the comparative hMeDIP-
seq data generated by this new approach is ready for direct
comparative analysis across multiple samples after nor-
malization of hMeDIP data by the corresponding input
data of each sample.
The new strategy used in the comparative hMeDIP-seq
method greatly facilitates later data processing. The com-
putational analysis for all the reads obtained from deep
sequencing is processed as a whole for the different
samples (ESCs versus NPCs) within the data collection.
Thus, it is simpliﬁed, straightforward and unbiased for all
reads alignment and all 5hmC peak calling. Indeed, we
have made signiﬁcant improvements in peak calling and
DHMR identiﬁcation. Pooled 5hmC peaks can be called
from the un-separated hMeDIP-seq data of multiple
samples as the sensitive DNA hydroxymethylated
regions. Then, we can compare the 5hmC density at
these sensitive DNA hydroxymethylated regions across
multiple samples. With this new strategy, we have
bypassed the problem of asymmetric peak widths and
numbers between samples and signiﬁcantly reduced the
work load for the data processing.
Recently, two new techniques (oxBS-seq and TAB-seq)
have been reported to distinguish 5hmC from 5mC at
single-base resolution (40,43). These two methods also
provided means to detect the absolute quantitative value
(percentage) of 5hmC in the genome. The single-base reso-
lution 5hmC sequencing approach revealed that the
absolute percentage of 5hmC in gene body regions
appears to be low, contrary to previous data from the
conventional hMeDIP-seq approach, which suggested
that gene body regions of ESCs tend to have a large
amount of 5hmC. Therefore, the conclusions drawn
from the two different approaches seem contradictory.
We believe that this discrepancy is likely caused by the
different measurement techniques of the two 5hmC-de-
tecting approaches. Gene body DNA (especially in
exons) has a relatively high frequency of CpG content
but low percentage of 5hmC at each CpG site. It is true
that the TAB-Seq method represents a more accurate
methodology to measure the absolute abundance of
5hmC at base pair resolution. However, as pointed out
by Yu et al. (40) in their Discussion, the TAB-seq
method likely underestimates relatively low abundances
of 5hmC sites within gene body, as these sites might
have escaped detection because of insufﬁcient coverage
of sequencing depth. Accordingly, an unexpectedly low
(underestimated) percentage of 5hmC within the gene
bodies was observed in this study (40). This shortcoming
could most likely be compensated by increasing the
sequencing depth, although this would increase the
cost even more, another limitation for routine usage of
these methods in an average laboratory at the current
stage. Conversely, conventional afﬁnity-based 5hmC
mapping (hMeDIP) is not only a cost-effective way to
quickly project the overall landscape of 5hmC along the
genome, but it also allows ampliﬁcation of high frequency
but weak 5hmC signals within gene bodies. The downside
of this measurement is that it determines 5hmC distribu-
tion at low resolution (counting 200–400bp as one unit). It
may also potentially over-amplify the weak signals of
those clustering individual 5hmC sites with low abun-
dances, adding up multiple weak 5hmC signals to make
it appear like one strong signal within 200–400bp window.
Therefore, it may introduce a potential overestimation of
the abundance of 5hmC in the gene bodies, outweighing
the low frequency, but high abundance, of 5hmC at
distal-regulatory elements such as the enhancers. Clearly,
both single-base resolution 5hmC-seq and hMeDIP-seq
approaches have their advantages and disadvantages.
The comparative hMeDIP method we describe in this
article retained all of the advantages from the conventional
Figure 5. Relationship between the changes in DNA
hydroxymethylation and gene expression during neural differentiation.
(a) Down- and up-regulated genes during neural differentiation were
sorted (NPC versus ESC, log2 mRNA expression ratio  1o r 1).
The changes in 5hmC peak density at promoters (TSS±1kb) in down-
and up-regulated genes were compared during neural differentiation
(P=0). *P<0.01. (b) The changes in 5hmC peak density at gene
body regions (from TSS+1kb to TES) in down- and up-regulated
genes were compared during neural differentiation (P=0). *P<0.01.
(c) Dot plotting of the alteration in 5hmC peak density at promoters
and the gene expression change during neural differentiation. The
changes in 5hmC peak density at promoters (TSS±1kb) were
plotted on the y-axis and the corresponding gene expression changes
were plotted on the x-axis. R
2=0.0048. (d) Dot plotting of the alter-
ation in 5hmC peak density in gene body regions and the gene expres-
sion change during neural differentiation. The changes in 5hmC peak
density in gene body regions (from TSS+1kb to TES) were plotted on
the y-axis and the corresponding gene expression changes were plotted
on the x-axis. R
2=0.0059.
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comings. The unique features of the comparative
hMeDIP-seq method, particularly the newly developed
algorithm for DHMR identiﬁcation, systematically elimin-
ate the conventional hMeDIP-seq-induced bias or potential
overestimation of 5hmC abundance for the low-5hmC
sample when the 5hmC abundance was compared among
multiple biological samples. If the research aim is to
identify DHMRs among samples, the optimized compara-
tive hMeDIP-seq method can fulﬁll this aim with much
lower cost and less experimental time. With no doubt, if
the research goal is to map the absolute 5hmC distribution
at base-pair resolution, oxBS- or TAB-seq is the method to
choose. However, to precisely locate 5hmC sites with low
abundance, oxBS- or TAB-seq would require much larger
sequencing coverage than hMeDIP-seq, thus increasing the
cost and amount of labour required. In the future, it would
be a good strategy to combine the advantages of the com-
parative hMeDIP-seq with the oxBS- or TAB-seq
approaches for studying the dynamic changes and precise
role of 5hmC in genome regulation during cell differenti-
ation and development. For example, we may use the com-
parative hMeDIP-seq to locate the genes or genomic
regions with most dramatic changes of 5hmC (DHMRs).
Then we can use targeted oxBS- or TAB-seq approaches to
sequence these targeted genomic fragments (located by the
comparative hMeDIP-seq approach) to map the precise
changes of 5hmC within the region at single base reso-
lution. By combining these two approaches, we envision
that we could quantitatively compare the localized 5hmC
changes between the different biological samples in a
cost-effective user-friendly manner while yielding better
resolution.
Upon neural differentiation, ESCs lose pluripotency and
gain the characteristics of neural lineage cells (44,45). Cell
differentiation involves drastic epigenomic reprogramming,
including the establishment of cell-speciﬁc DNA
methylome and hydroxymethylome (11,46). The DNA
methylomes of ESCs and NPCs have been well established
by MeDIP-seq and Bisulﬁte-seq in the past few years
(47,48). Although the DNA hydroxymethylome of ESCs
has been established recently by afﬁnity-based approach
or new sequencing methods at single base resolution, the
DNA hydroxymethylome of NPCs remained unknown. In
this study, using the newly developed comparative
hMeDIP-seq method, we revealed a dramatic loss of
5hmC during neural differentiation of mouse ESCs and
provided the ﬁrst genome-wide comparative 5hmC map
of NPCs in conjunction with that of the ESCs. We found
that the 5hmC distribution pattern of NPCs is vastly dif-
ferent from that of ESCs: the majority of 5hmC peaks that
exist in ESCs are lost in NPCs, whereas a small fraction of
gene loci undergo de novo DNA hydroxymethylation.
Many regions that undergo de novo DNA hydroxy-
methylation are located at genes associated with mature
neuronal functions. We speculate that these genes may be
repressed by 5hmC or its associated cellular complex (es) in
NPCs, but are poised for DNA demethylation, and as a
result can undergo gene activation upon later stages of
neural differentiation and maturation.
In agreement with the previous ﬁndings, the compara-
tive hMeDIP-seq method revealed a complex correlation
between 5hmC distribution and gene activity in both ESC
and NPC. We found that the 5hmC levels at promoters
(TSS±1kb) had a negative correlation with gene expres-
sion in both ESCs and NPCs, whereas the correlation
between 5hmC levels in gene body regions and gene ex-
pression varied depending on the cell type. ‘Loss of 5hmC’
happens at down-regulated, up-regulated and unchanged
genes during neural differentiation; however, there was a
weak, but signiﬁcant, positive correlation between the
changes in 5hmC and gene expression. These results
suggest that 5hmC patterns are likely another layer of
largely uncharacterized epigenetic regulation within the
larger landscape of cell-speciﬁc chromatin structure. It is
possible that 5hmC in the gene body may not be an essen-
tial and driving force for gene transcription, but rather,
gene transcriptional activity at a steady state may affect
5hmC generation by regulating the access of TET proteins
towards their DNA substrates. Finally, it has been
proposed that DNA methylation in gene body regions
may inhibit cryptic transcription and correlate with gene
expression (49). DNA methylation in gene body regions
has also been reported to regulate alternative promoters
and splicing (50,51). In the future, it will be of great
interest to investigate whether DNA hydroxymethylation
in gene body regions also affects alternative promoters
and mRNA splicing.
In summary, future investigation is required to dissect
the intrinsic and intricate relationship between dynamic
changes of 5hmC and speciﬁc gene expression within the
same cell type or during cell differentiation. Nonetheless,
our data demonstrate that the comparative hMeDIP-seq
method is a powerful approach for genome-wide compari-
sons of DNA hydroxymethylation across multiple
samples. Using this method, we have uncovered the dif-
ference in DNA hydroxymethylation between ESCs and
NPCs. Notably, the strategies described here can also be
applied to the genome-wide quantitative comparison of
other DNA modiﬁcations (such as 5mC, 5caC and 5fC)
across different biological or pathological samples.
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